Cancer
To meet the medical needs of patients, we have made oncology one of our priorities.
Our therapeutic areas
THERAPEUTIC AREAS
Listening to patients to provide them with the most effective solutions
We harness our expertise to provide patients with medicines in over 150 countries. We focus our efforts on indications with significant medical need.
Involving patients enables us to design suitable therapeutic solutions in each of our four therapeutic areas.
Focus on four key therapeutic areas
We are a world leading pharmaceutical group in cardiometabolism and the treatment of venous diseases. In oncology, we aim at developing precision therapies with a transformative clinical benefit for cancer patients lives. We are also involved in neuroscience and immune-inflammatory diseases. To increase the pace of innovation oriented to meet patient needs, we champion collaboration and constant dialogue between those involved in health care in both the public and private sectors, it takes an open and collaborative approach, working with academic partners, pharmaceutical groups and biotech companies.
Putting patients at the heart of our strategy
We put patients and innovation at the heart of everything we do. To meet their needs, we work with patients at every stage of the medicine life cycle—from research to appropriate use—before, during and after treatment.
We believe it is essential. For science. For patients.
Focus
28 medicines available to patients in over 150 countries